Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure
- 1 December 2002
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 113 (9), 717-722
- https://doi.org/10.1016/s0002-9343(02)01394-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse OutcomesCirculation, 2001
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Apoptosis in the Failing Human HeartNew England Journal of Medicine, 1997
- Cardiac troponin I and troponin T: Are enzymes still relevant as cardiac markers?Clinica Chimica Acta; International Journal of Clinical Chemistry, 1997
- Apoptosis in Myocytes in End-Stage Heart FailureNew England Journal of Medicine, 1996
- Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding proteinJournal of Immunological Methods, 1995
- Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in manMolecular and Cellular Biochemistry, 1992
- Serum and urinary human heart fatty acid-binding protein in acute myocardial infarctionClinical Biochemistry, 1991
- Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradoxBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Fatty acid binding proteins from heartChemistry and Physics of Lipids, 1985